1. Home
  2. FGEN

FGEN

FibroGen Inc

Logo FibroGen Inc

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Founded: N/A Country:
United States
United States
Employees: N/A City: SAN FRANCISCO
Market Cap: 160.0M IPO Year: 2014
Target Price: $5.00 AVG Volume (30 days): 2.8M
Analyst Decision: Sell Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.92 EPS Growth: N/A
52 Week Low/High: $0.33 - $20.90 Next Earning Date: 05-06-2024
Revenue: $147,752,000 Revenue Growth: 4.99%
Revenue Growth (this year): 9.32% Revenue Growth (next year): 7.00%

Share on Social Networks: